CRISPR Therapeutics AG (CRSP) Earnings Report - Discounting Cash Flows
CRISPR Therapeutics AG
CRSP (NASDAQ)
Period Ending: 2025
11-03
2025
08-04
2025
05-06
2025
02-11
2024
11-05
2024
08-05
2024
05-08
2024
02-21
2023
11-06
2023
08-07
2023
05-08
2023
02-21
2022
11-01
2022
08-08
2022
05-09
2022
02-15
2021
11-03
2021
07-29
2021
04-27
2021
02-16
2020
10-28
2020
07-27
2020
04-28
2020
02-12
2019
10-28
2019
07-29
2019
04-29
2019
02-25
2018
11-07
2018
08-07
2018
05-08
2018
03-08
2017
11-08
2017
08-10
2017
05-11
2017
03-10
2016
11-22
2016
10-19
2016
03-30
2015
12-30
2015
09-29
2015
06-29
2015
03-30
Actual EPS - - -1.58 -0.44 -1.01 -1.49 -1.43 1.10 -1.41 -0.98 -0.67 -1.41 -2.24 -2.40 -2.32 -1.84 -1.67 9.44 -1.51 -1.50 -1.32 -1.30 -1.15 0.51 2.40 -1.01 -0.93 -0.92 -1.07 -0.82 -0.62 0.00 -0.62 -0.56 -0.54 -0.40 -2.77 -0.43 -0.29 -0.42 -0.22 -0.66 -0.91
Estimated EPS - -1.54 -1.27 -1.15 -1.33 -1.37 -1.63 -0.07 -1.98 -2.18 -1.67 -2.32 -2.30 -2.23 -1.91 -1.74 -1.69 3.52 -1.45 -1.23 -1.17 -0.92 -1.09 -0.63 -0.95 -0.81 -0.88 -0.83 -0.74 -0.65 -0.67 -0.67 -0.60 -0.62 -0.51 -0.38 -0.72 - - - - - -
Actual Revenue - - 0.865 35 0.602 0.517 0.504 200 - 70 100 0.006 0.094 0.158 0.178 12.35 0.329 900.2 0.202 0.194 0.148 0.044 0.157 77.02 211.9 0.318 0.328 0.115 0.563 1.09 1.36 32.33 2.39 3.58 2.7 2.34 1.55 0.795 0.476 0.247 - - -
Estimated Revenue - 6.44 5.96 8.06 7.7 16.57 3.54 28.11 7.96 1.71 1.71 0.023 1.85 2.21 2.8 2.19 0.834 845.9 1.21 2.5 0.132 0.032 0.143 95.14 83.89 0.283 0.31 0.098 0.389 0.836 1.47 - 2.31 3.97 3.05 0.809 2.58 - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us